Novavax has been provisionally approved for use in Australia, which health authorities hope will drive Covid-19 vaccine rates close to 100 per cent.
Health Minister Greg Hunt said the Therapeutic Goods Administration had given the final tick to the vaccine, making it the first Covid-19 protein vaccine to receive regulatory approval.
The TGA said Novavax was approved for use in Australians 18 years and older, with two doses given three weeks apart.
At this stage, Novavax is only approved for use as a primary course and not for boosters.
Mr Hunt said there were 51 million units of the vaccine on order.
“Obviously we have a first dose national vaccination rate of 95.2 per cent, and we know some people have waited for Novavax,” Mr Hunt said.
“Hopefully this will encourage those people in that less than five per cent to come forward and be vaccinated.”
